KFDA to evaluate safety and efficacy of 202 off-label drugs by 2015

Published: 2010-04-05 06:58:00

Updated: 2010-04-05 06:58:00

The Korea Food and Drug Administration has unveiled its plan to evaluate the safety and efficacy of 202 off-label drugs by 2015 through review of clinical data to see if the results support the drug for a specific use or indication.

Off-label use is the practice of prescribing pharmaceuticals ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK